HBV and HCV as Risk Factors for Hepatocellular Carcinoma
Archives of Surgery and Clinical Research · 23.07.2026 · 13-19
DOI: 10.29328/journal.ascr.1001097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Surgery and Clinical Research, online erschienen am 23.07.2026. Verfasst von Edina Bilic-Komarica. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular liver cancer (HCC) is associated with a high incidence of chronic hepatitis B and C aetiology. Hepatocellular cancer must not always be preceded by cirrhotic liver disease. In the pathogenesis of cirrhosis, the liver is dominated by three pathological processes, including hepatocyte necrosis (cell death), fibrosis and regeneration. Cirrhosis, with its histological characteristics, is a precancerous condition that leads to the development of cancer. Viruses B or C, in their presence in the liver parenchyma, trigger an inflammatory process followed by hepatocyte necrosis. Chronic active hepatitis B and C aetiology is a major medical problem since viruses, by their presence and incorporation in the hepatocyte genome, trigger the pathological process leading to HCC. Alpha-fetoprotein (AFP) is the most important diagnostic marker for HCC. It has relatively high specificity and sensitivity and is widely applied in practice. With this research, we will point out all known facts about the increase of Hepatocellular carcinoma (HCC) in men and women with hepatitis B and C aetiology. The research highlights the importance of diagnosing hepatitis, the polymerase chain reaction, and the serological reaction very important for the quantification of the virus in the serum of the diseased, as well as the histological findings of the liver obtained by taking a biopsy sample by percutaneous liver biopsy. A particular review is given on the epidemiological significance of hepatitis, as viral infections spread throughout the Earth's sphere, as well as viruses declared to be biological carcinogens. Also, the research has given great importance to AFP as a significant carcinoma antigen in diagnosing HCC.
Zitieren
APA
Bilic-Komarica, E. (2026). HBV and HCV as Risk Factors for Hepatocellular Carcinoma. Archives of Surgery and Clinical Research, 13-19. https://doi.org/10.29328/journal.ascr.1001097
Vancouver
Bilic-Komarica E. HBV and HCV as Risk Factors for Hepatocellular Carcinoma. Archives of Surgery and Clinical Research. 2026:13-19. doi:10.29328/journal.ascr.1001097
BibTeX
@article{BilicKomarica2026,
author = {Bilic-Komarica, Edina},
title = {HBV and HCV as Risk Factors for Hepatocellular Carcinoma},
journal = {Archives of Surgery and Clinical Research},
year = {2026},
pages = {13--19},
doi = {10.29328/journal.ascr.1001097}
}
EUVIMED